GLAXOGlaxoSmithKline PharmaceuticalsGLAXO info
$33.57info-1.20%24h
Global rank2480
Market cap$5.69B
Change 7d-0.50%
YTD Performance47.91%
SP500 benchmarkOutperform
P/E0.93
P/S14.69
Revenue$387.19M
Earnings$72.72M
Dividend yield-
Main Sector
Healthcare

GlaxoSmithKline Pharmaceuticals (GLAXO) Stock Overview

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella; and Shingrix for prevention of Shingles and Post herpetic neuralgia. It also provides specialty medicines comprising NUCALA for severe eosinophilic asthma; and TRELEGY ELLIPTA for treating chronic obstructive pulmonary disease. In addition, the company offers general medicines, including AUGMENTIN and CEFTUM, which are antibiotics to treat bacterial infections; CALPOL for treatment of mild to moderate pain; ELTROXIN for hypothyroidism; CCM to treat calcium and vitamin D deficiency; NEOSPORIN for treatment and prevention of specific bacterial skin infections; BETNOVATE for skin conditions which require relief of inflammation; T-BACT for bacterial skin infections; TENOVATE and Flutivate for skin conditions to reduce inflammation; PHYSIOGEL for dry skin and dry skin associated with redness and itch; Zimig for fungal skin infections; COBADEX CZS, a multivitamin; and Supacef, a bactericidal cephalosporin antibiotic. Further, it develops products for infectious diseases, HIV, oncology, and immunology. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.

GLAXO Stock Information

Symbol
GLAXO
Address
GSK HouseMumbai, 400030India
Founded
-
Trading hours
-
Website
https://india-pharma.gsk.com
Country
🇮🇳 India
Phone Number
91 22 2495 9595

GlaxoSmithKline Pharmaceuticals (GLAXO) Price Chart

-
Value:-

GlaxoSmithKline Pharmaceuticals Overview: Key Details and Summary

Stock data
2023
Change
Price
$33.57
N/A
Market Cap
$5.69B
N/A
Shares Outstanding
169.41M
0.00%
Employees
3.68K
N/A
Shareholder Equity
17.41B
-34.61%
Valuation
2023
Change
P/E Ratio
0.93
N/A
P/S Ratio
14.69
N/A
P/B Ratio
0.33
N/A
Growth
2023
Change
Return on Equity
0.0042
N/A
Earnings
2023
Change
Revenue
$387.19M
N/A
Earnings
$72.72M
N/A
EPS
36.05
N/A
Earnings Yield
1.07
N/A
Gross Margin
0.5822
N/A
Operating Margin
0.2302
N/A
Net income margin
0.1878
N/A
Financial Strength
2023
Change
Total Assets
$396.10M
N/A
Total Debt
$1.85M
N/A
Cash on Hand
$213.35M
N/A
Debt to Equity
0.0108
23.05%
Cash to Debt
$115.31
-20.25%
Current Ratio
$1.88
-13.86%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org